Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 048187/0401 | |
| Pages: | 66 |
| | Recorded: | 01/30/2019 | | |
Attorney Dkt #: | H0664.700076US00 |
Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER: 9685579 PREVIOUSLY RECORDED ON REEL 046609 FRAME 0822. ASSIGNOR(S) HEREBY CONFIRMS THE ASSET PURCHASE BY WAY OF DEED. |
|
Total properties:
5
|
|
Patent #:
|
|
Issue Dt:
|
03/05/2019
|
Application #:
|
14405950
|
Filing Dt:
|
12/05/2014
|
Publication #:
|
|
Pub Dt:
|
08/25/2016
| | | | |
Title:
|
SYNERGISTIC THERAPIES OF CANNABIDIOL WITH HYPOTHERMIA FOR NEUROPROTECTION
|
|
|
Patent #:
|
|
Issue Dt:
|
06/13/2017
|
Application #:
|
14785055
|
Filing Dt:
|
10/16/2015
|
Publication #:
|
|
Pub Dt:
|
03/17/2016
| | | | |
Title:
|
TETRAHYDROCANNABIVARIN FOR USE IN THE TREATMENT OF NAUSEA AND VOMITING
|
|
|
Patent #:
|
|
Issue Dt:
|
10/16/2018
|
Application #:
|
14899613
|
Filing Dt:
|
12/18/2015
|
Publication #:
|
|
Pub Dt:
|
05/19/2016
| | | | |
Title:
|
THE USE OF PHYTOCANNABINOIDS IN THE TREATMENT OF OVARIAN CARCINOMA
|
|
|
Patent #:
|
|
Issue Dt:
|
05/08/2018
|
Application #:
|
15321766
|
Filing Dt:
|
12/23/2016
|
Publication #:
|
|
Pub Dt:
|
05/25/2017
| | | | |
Title:
|
ACTIVE PHARMACEUTICAL INGREDIENT (API) COMPRISING CANNABINOIDS FOR USE IN THE TREATMENT OF CANCER
|
|
|
Patent #:
|
|
Issue Dt:
|
08/07/2018
|
Application #:
|
15321778
|
Filing Dt:
|
12/23/2016
|
Publication #:
|
|
Pub Dt:
|
05/11/2017
| | | | |
Title:
|
7-HYDROXY CANNABIDIOL (7-OH-CBD) FOR USE IN THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
|
|
Assignee
|
|
|
SOVEREIGN HOUSE |
VISION PARK |
HISTON, CAMBRIDGE, CAMBRIDGESHIRE, UNITED KINGDOM CB24 9BZ |
|
Correspondence name and address
|
|
WOLF GREENFIELD & SACKS
|
|
600 ATLANTIC AVENUE
|
|
BOSTON, MA 02210
|
Search Results as of:
09/20/2024 12:54 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|